Quick answer
A flat scale does not explain why progress has slowed. Weight-management results differ between people, and your prescriber needs more than a single reading to assess your response. Start with your weight record, medication history and any symptoms. Do not increase, combine or change prescription medicines to force a result. NIDDK medication guidance.
This guide helps you prepare that conversation. It cannot tell you whether your treatment is effective or choose a treatment change for you.
Start with the question your record can answer
“I am not losing weight” can describe several situations: you have not noticed a change since starting, you previously lost weight and now see similar readings, or your readings move up and down. Describe which one applies before calling it a plateau.
Bring the dates and measurements you already have. Note whether you changed scales or weighed yourself under different conditions. Ask your clinician how often tracking is useful for you. You do not need to begin frequent weighing to make this appointment worthwhile.
If you do not have a record, say so. A rough recollection is still worth discussing, but label it as a recollection rather than making up a starting number.
Why the scale may need a broader review
NIDDK explains that the body uses fewer calories after weight loss and that metabolic and hormonal changes can make maintaining weight loss difficult. This is one reason the same routine may not produce an identical trend indefinitely. It does not establish the reason for your particular stall. NIDDK on weight maintenance.
Other information matters too. Health conditions, medicines, sleep and daily circumstances can affect weight. Tell your clinician about changes rather than assuming the answer must be a higher dose. NIDDK on factors affecting weight.
Your appointment worksheet
Copy the prompts below into a private note. The purpose is to organize a conversation, not calculate a diagnosis.
| Bring | Write down | Ask |
|---|---|---|
| Weight history | Available dates and readings; when the pattern changed | Does this record show a meaningful change in my response? |
| Medication list | Exact product names, other prescriptions and supplements | Could anything on this list affect the assessment? |
| Treatment interruptions | Missed treatment, refill gaps or uncertainty about instructions | How should I handle the situation safely? |
| Symptoms | Appetite changes, nausea, vomiting, constipation or other concerns | Does anything need assessment before we discuss weight? |
| Daily routine | Changes in meals, sleep, movement or practical access to food | Which change would be useful and realistic for me? |
| Your priorities | Energy, comfort, function and the concern that prompted this visit | What should we monitor besides the scale? |
Add one sentence at the top: “The main thing I want help understanding is ____.” That gives your appointment a clear starting point without deciding the cause in advance.
When symptoms take priority
Do not treat severe symptoms as a plateau problem. MedlinePlus, the National Library of Medicine's drug information service, tells people using semaglutide injection to tell their doctor if nausea, vomiting, diarrhea or stomach pain is severe or does not go away, and it lists severe stomach or intestinal problems among the side effects that can be serious. MedlinePlus: semaglutide injection.
Those instructions come from a general drug information page, not from the label of any compounded product. Follow the safety instructions for your own prescription; this article does not establish equivalence between different semaglutide products.
Related reading
For personal treatment decisions, speak with your prescribing clinician. This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved as final products. Medication is prescribed only if a licensed physician determines it is appropriate. Sources checked September 29, 2026.
Frequently Asked Questions
Does a plateau mean semaglutide has stopped working?
The weight record alone cannot establish that. Ask your prescriber to assess the pattern alongside your treatment, symptoms and health goals. An online checklist cannot make that decision.
Should I increase my dose if the scale is flat?
Do not change your prescription on your own. Bring the concern to your prescriber, including any missed treatment or uncertainty about your instructions.
Is there a food that breaks a plateau?
This guide does not recommend a food as a treatment for a stall. A useful next step is reviewing your overall eating pattern with someone who understands your health needs.
Should I stop tracking my weight?
Ask what monitoring is appropriate for you. If weighing feels distressing or changes how you eat, tell your clinician so that your follow-up plan can account for that concern.
What should I bring if I have no measurements?
Bring your medication list, your best account of what changed and any symptoms. You can arrange future monitoring at the visit rather than delaying care to create a perfect record.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.Prescription Medications to Treat Overweight & Obesity · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 2.Eating & Physical Activity to Lose or Maintain Weight · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 3.Factors Affecting Weight & Health · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · accessed
- 4.Semaglutide Injection (drug information, last revised May 15, 2026) · American Society of Health-System Pharmacists (AHFS), via MedlinePlus · accessed
Is this available in your state?
Telehealth rules differ by state, and so does what a physician can prescribe remotely. Each state page covers the local telehealth requirements, whether a video visit is required, and the current status of our physician coverage there.
- California
- Texas
- Florida
- New York
- Pennsylvania
- Illinois
- Ohio
- Georgia
- North Carolina
- Michigan
- Arizona
- Washington
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them